Why IVF cycle flow deserves a value stream view
In the realm of fertility care, clinical quality and operational flow are inseparable. Patients need safe, evidence-based treatment, but they also need predictable scheduling, clear communication, reliable handoffs, and minimal avoidable waiting.
Value Stream Mapping (VSM) makes the complete patient and information journey visible. Rather than examining only the consultation, monitoring visit, theatre list, or embryology workflow in isolation, the clinic sees how every step connects, from referral through embryo transfer.
This case study uses a hypothetical fertility clinic handling 120 stimulated cycles per month across 22 working days. The objective is not to accelerate clinical decisions or compromise care. It is to reduce avoidable delay, variation, rescheduling, and administrative friction while protecting patient-defined value.
The approach aligns with healthcare VSM guidance from NHS Quality, Service Improvement and Redesign, which recommends mapping patient flow, information flow, waiting, process time, and future-state opportunities.
Scope: define the IVF value stream before changing it
The primary scope is:
First specialist fertility consultation through to embryo transfer in a fresh IVF cycle.
The map includes:
- Specialist consultation and baseline hormone and ultrasound workup
- Treatment planning, consent, medication teaching, and protocol scheduling
- Ovarian stimulation and monitoring
- Egg collection
- Embryology culture through day-five blastocyst
- Fresh embryo transfer
- Supporting information flow between patients, clinicians, nurses, theatre, pharmacy, and embryology
The following are shown as boundary queues but are outside the main improvement scope:
- Referral-to-consultation waiting time, because it occurs before the specialist consultation
- Luteal support and pregnancy testing, because it occurs after embryo transfer
- Long-term outcomes beyond the first-cycle success measure
This distinction prevents scope drift while ensuring that upstream and downstream queues remain visible.
Demand, takt time, and the pacemaker process
The clinic receives demand for:
- 120 stimulated cycles per month
- 22 working days per month
- Approximately 5.5 cycles per day
The cycle coordination team has 600 available minutes per day.
[
\text{Takt Time}=\frac{\text{Available Time}}{\text{Customer Demand}}
]
[
\text{Takt Time}=\frac{600}{5.5}=109.1\text{ minutes per cycle}
]
The coordination team therefore needs to complete one cycle-coordination workload approximately every 109 minutes to meet average demand.
Takt time is not a target for shortening clinical treatment. It is a capacity and scheduling signal. It helps the team identify whether the coordination workload, monitoring appointments, theatre capacity, and embryology handoffs are balanced with demand.
Current-state map: where the 68 days go
The current state shows a 68-day door-to-door lead time, while value-added clinical contact time is approximately 2.6 days. That produces a flow efficiency of:
[
\frac{2.6}{68}\times100=3.8%
]
Rounded, the clinic is operating at approximately 4% flow efficiency.
To make the 68-day baseline auditable, the map assigns the unallocated administrative delay to protocol approval, consent completion, medication teaching, and scheduling queues. The clinic should validate these figures through direct observation and timestamp data.
| Current-state step | Elapsed time | Approx. value-added time | Typical flow issue |
|---|---|---|---|
| Referral to first specialist consultation | 14 days | 0.05 days | Appointment queue before clinical assessment |
| Consultation and baseline hormone/ultrasound workup | 2 days | 0.35 days | Results, orders, and treatment decisions handled across separate handoffs |
| Protocol approval, consent, medication teaching, and cycle scheduling | 19 days | 0.20 days | Approval queues, incomplete information, and appointment availability |
| Stimulation and monitoring | 12 days | 0.75 days | Five monitoring visits; 22% are rescheduled at least once |
| Egg collection | 1 day | 0.40 days | Theatre list variation and changeover losses |
| Embryology culture to blastocyst | 5 days | 0.50 days | Lab schedule is largely push-based |
| Embryo transfer | 1 day | 0.25 days | Readiness checks and scheduling handoffs |
| Luteal support and pregnancy test | 14 days | 0.10 days | Downstream boundary activity |
| Total | 68 days | 2.6 days | Approximately 3.8% flow efficiency |
The current state also reports:
- First-cycle live birth rate: 38%
- Cycle cancellation rate: 11%
- Booked patients dropping off before transfer: 17%
- Monitoring appointments rescheduled: 22%
- Egg-collection theatre utilisation: 64%
The most important observation is that the longest clinical activities are not necessarily the greatest sources of delay. The dominant issue is the accumulation of queues between activities.
The eight DOWNTIME wastes in the fertility pathway
A VSM should translate visible delay into specific improvement opportunities. The DOWNTIME framework provides a practical structure.
-
Defects
Missing referrals, incomplete consent forms, incorrect medication instructions, or unavailable laboratory results create rework and can contribute to cancellation. -
Overproduction
Producing duplicate reports, preparing schedules before key clinical information is confirmed, or generating repeated patient communications creates work that may need revision. -
Waiting
The 14-day referral queue, 19-day scheduling and approval queue, monitoring reschedules, and theatre availability are visible waiting states. -
Non-utilised talent
Nurses, coordinators, embryologists, and administrative staff may spend time chasing information instead of applying their specialist capability to patient care and process improvement. -
Transportation
Physical movement of paper forms, samples, or documents between clinic areas can create handoff risk and delay. Digital and controlled specimen pathways should be assessed carefully for safety and compliance. -
Inventory
Work in process includes booked-but-not-ready cycles, incomplete consent packs, pending lab results, and patients waiting for a confirmed monitoring slot. -
Motion
Repeated movement between reception, consultation rooms, ultrasound, blood collection, theatre, and laboratory interfaces can extend patient and staff time. -
Extra processing
Re-entering data into multiple systems, repeated approval checks, duplicate documentation, and unnecessary status calls add effort without increasing clinical value.
These wastes should not be removed through assumption. The team should validate them using observation, patient feedback, timestamp analysis, and a Voice of the Customer review. In fertility care, value includes clinical safety, dignity, clarity, emotional support, and dependable scheduling, not simply speed.
Future-state design: build flow around the constraint
The future state targets a reduction in total lead time from 68 to 42 days. The design principles are:
- Establish one visible coordination pathway from consultation to transfer
- Use standard work for protocol scheduling and readiness checks
- Create a fixed daily monitoring block
- Replace push scheduling with pull signals from downstream capacity
- Protect theatre capacity through faster, more consistent changeover
- Make cycle status visible through daily tiered huddles
- Escalate variation early rather than allowing it to accumulate
The future-state sequence is:
-
Consultation and baseline workup
Use a complete-first-pass referral and diagnostic checklist so treatment planning begins with the required information. -
Standardised stimulation protocol scheduling
Level appointments against demand and available capacity. Use a defined scheduling window, clear approval rules, and a readiness checklist. -
One-piece-flow monitoring
Reserve a fixed daily monitoring block so each patient moves through ultrasound, bloodwork, review, and dose communication with fewer disconnected queues. -
Pull-based embryology scheduling
Use the next required laboratory capacity to signal upstream readiness. This creates a controlled pull rather than releasing cycles into an unbalanced schedule. -
SMED-style theatre changeover
Separate internal and external changeover work, prepare equipment and documentation before the list, and standardise room turnover activities. -
Visual control and escalation
A cycle board should show each patient pathway by status, without exposing unnecessary personal information. An Andon-style signal can alert the team to a missing result, delayed approval, capacity conflict, or clinical exception in real time.
Current versus future performance
The future-state figures below are operational targets for the improvement project. Clinical outcomes must continue to be governed by appropriate medical protocols and patient-specific decisions.
| Metric | Current state | Future-state target |
|---|---|---|
| Door-to-door cycle lead time | 68 days | 42 days |
| Approx. value-added process time | 2.6 days | 3.5 days |
| Flow efficiency | 3.8% | Above 8% |
| First-cycle live birth rate | 38% | Maintain or improve toward 40% |
| Cycle cancellation rate | 11% | Below 4% |
| Patient drop-off before transfer | 17% | Below 8% |
| Monitoring appointment reschedules | 22% | Below 8% |
| Egg-collection theatre utilisation | 64% | Above 85% |
The increase in measured process time in the future state does not mean adding unnecessary work. It reflects more reliable first-pass preparation, complete patient education, and controlled handoffs being performed within the flow rather than being scattered across queues and rework loops.
Connecting VSM to DMAIC
VSM becomes particularly powerful when linked to DMAIC:
- Define: Establish the patient CTQs, scope, business case, stakeholders, and project charter.
- Measure: Capture lead time, wait time, process time, cancellation, drop-off, rescheduling, theatre utilisation, and first-pass completeness.
- Analyse: Use Pareto analysis, process stratification, box plots, and root-cause analysis to separate common-cause variation from special-cause events.
- Improve: Test standard work, capacity levelling, pull scheduling, fixed monitoring blocks, and theatre changeover improvements.
- Control: Maintain visual boards, daily huddles, control charts, ownership, audit rules, and escalation triggers.
The Lean 6 Sigma Hub Process Cycle Efficiency Calculator can help quantify the relationship between value-added time, waiting, and total lead time.
A SigmaFlow Value Stream Mapping workspace can support this structure by providing a visual mapping canvas, activity-level data, takt-time calculations, benchmarking, and Lean Six Sigma scorecards. The SigmaFlow VSM reference manual describes a workflow for mapping process steps, information flow, activity data, and takt time in one environment.
90-day kaizen sequence
Days 1–30: Stabilise and see the work
- Confirm the current-state map through direct observation.
- Validate the 68-day timeline and the 2.6-day process-time baseline.
- Create standardised stimulation protocol scheduling rules.
- Level demand across the 22 working days.
- Establish a fixed daily monitoring block.
- Launch daily tiered huddles using a visual cycle board.
- Track cancellation, drop-off, rescheduling, and theatre utilisation daily.
Days 31–60: Improve flow at the constraints
- Pilot one-piece-flow monitoring appointments.
- Introduce a pull signal from embryology to cycle coordination.
- Define a controlled FIFO queue for patients who are clinically ready.
- Run a SMED-style theatre changeover workshop.
- Separate preparation activities from theatre-list changeover time.
- Review approval checkpoints and remove duplicate administrative review while retaining governance.
Days 61–90: Control and scale
- Compare current and future-state performance using weekly run charts.
- Confirm whether monitoring reschedules are below 8%.
- Confirm whether theatre utilisation is trending above 85%.
- Audit protocol scheduling adherence and first-pass readiness.
- Update standard work and escalation rules.
- Assign process owners for coordination, monitoring, theatre, embryology, and patient communication.
- Prepare a replication plan for frozen-transfer or other high-volume pathways.
Turn fertility process improvement into a professional capability
A fertility clinic value stream is a complex service system involving clinical judgement, sensitive patient needs, laboratory precision, scheduling constraints, and regulatory governance. VSM gives leaders a disciplined way to improve the system without reducing care to a series of transactions.
If you want to lead this type of work, build capability through structured training in Lean Six Sigma, DMAIC, process analysis, waste reduction, root-cause analysis, and statistical decision-making. Explore the Lean Six Sigma online training programmes, including CSSC-accredited pathways from White Belt through Black Belt.
Start your Lean Six Sigma certification journey and learn to turn complex patient pathways into safer, clearer, higher-performing value streams.
Kaizen. Kai-Care. Kai-Done. Lean Six Sigma.
